Free Trial

Rigel Pharmaceuticals (RIGL) SEC Filings & 10K Form

Rigel Pharmaceuticals logo
$19.23 -1.31 (-6.39%)
As of 12:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Rigel Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/19/2025
7:55 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
7:56 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:41 PM
Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/10/2025
4:42 PM
Frohlich Mark W (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:22 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:18 PM
ARMISTICE CAPITAL, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/07/2025
12:42 PM
Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/06/2025
7:26 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
7:27 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
2:40 PM
Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:41 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:43 PM
Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
2:58 PM
Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/04/2025
3:39 PM
Rigel Pharmaceuticals (Subject)
Schorno Dean L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:30 PM
Rigel Pharmaceuticals (Subject)
RODRIGUEZ RAUL R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:20 PM
Rigel Pharmaceuticals (Subject)
Santos David A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/04/2025
3:21 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:45 PM
Furey Raymond J. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
5:47 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
7:49 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:38 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:15 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
7:01 PM
Rigel Pharmaceuticals (Issuer)
Santos David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
8:33 AM
Invesco Ltd. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G
11/07/2024
3:22 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:01 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:36 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:33 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
7:30 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2024
11:15 PM
Rigel Pharmaceuticals (Filer)
Form EFFECT
Alert: DOGE goes live (Ad)

Elon will most likely be at the helm of it all. And just days from now, could bring about the biggest economic transformation in American history. See, there's one particular part of Elon and Trump's plans that you need to pay special attention to right now.

06/27/2024
3:31 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
7:45 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:19 PM
Ali-Jackson Kamil (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
HANNAH ALISON L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:20 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:21 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
6:21 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
3:06 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
3:05 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2024
7:05 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
4:29 PM
Rigel Pharmaceuticals (Filer)
Form ARS
04/10/2024
3:49 PM
Rigel Pharmaceuticals (Filer)
Form DEF 14A
04/10/2024
3:50 PM
Rigel Pharmaceuticals (Filer)
Form DEFA14A
03/29/2024
4:04 PM
Rigel Pharmaceuticals (Filer)
Form PRE 14A
03/29/2024
3:09 PM
Rigel Pharmaceuticals (Issuer)
Rojkjaer Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:RIGL) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners